HK1049104A1 - Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses - Google Patents

Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Info

Publication number
HK1049104A1
HK1049104A1 HK02109229.2A HK02109229A HK1049104A1 HK 1049104 A1 HK1049104 A1 HK 1049104A1 HK 02109229 A HK02109229 A HK 02109229A HK 1049104 A1 HK1049104 A1 HK 1049104A1
Authority
HK
Hong Kong
Prior art keywords
illnesses
influenza
prophylaxis
cold
treatment
Prior art date
Application number
HK02109229.2A
Other languages
Chinese (zh)
Inventor
Seymour Gantenberg Nicholas
Ernest Singer Robert Jr
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HK1049104A1 publication Critical patent/HK1049104A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
HK02109229.2A 1999-07-30 2002-12-19 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses HK1049104A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36494499A 1999-07-30 1999-07-30
PCT/US2000/020658 WO2001008671A2 (en) 1999-07-30 2000-07-28 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Publications (1)

Publication Number Publication Date
HK1049104A1 true HK1049104A1 (en) 2003-05-02

Family

ID=23436803

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109229.2A HK1049104A1 (en) 1999-07-30 2002-12-19 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Country Status (10)

Country Link
EP (1) EP1221949A2 (en)
JP (1) JP2003505500A (en)
CN (1) CN1377262A (en)
AU (1) AU6240200A (en)
CA (1) CA2379703A1 (en)
CO (1) CO5200850A1 (en)
HK (1) HK1049104A1 (en)
PE (1) PE20010540A1 (en)
TR (1) TR200200246T2 (en)
WO (1) WO2001008671A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878751B1 (en) 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
ITRM20020562A1 (en) * 2002-11-06 2004-05-07 Sigma Tau Ind Farmaceuti USE OF THE RESVERATROL FOR THE PREPARATION OF A USEFUL DRUG FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS.
RU2007132963A (en) * 2005-02-04 2009-03-10 Петер ХЕГЕР (DE) METHOD FOR PRODUCING HYDROXYSTILBEN CONTAINING EXTRACT OF MEDICINAL RAW MATERIAL
EP1844784B1 (en) * 2006-03-28 2010-04-21 Epitech Group S.r.l. A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
CN100453071C (en) * 2006-11-03 2009-01-21 李万忠 Oral resveratrol multi-phase liposome and preparation method thereof
WO2008136173A1 (en) * 2007-04-20 2008-11-13 Ochanomizu University Adipocyte differentiation inhibitor containing stilbene derivative as active ingredient
ES2703737T3 (en) 2008-01-08 2019-03-12 David Rubin Method and compositions to preserve wine
FR2933871B1 (en) * 2008-07-18 2012-12-14 Yvery FORMULATION FOR IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE
DK2544705T3 (en) * 2010-03-12 2016-09-19 Synairgen Res Ltd INTERFERON BETA TO USE IN THE LOWER AIR TRANSMISSION CAUSED BY INFLUENZA
JP5848042B2 (en) 2011-06-29 2016-01-27 株式会社ロッテ Eye fatigue inhibiting composition and food and drink containing the same
US20140303260A1 (en) * 2011-10-19 2014-10-09 Nad Life Pty Ltd Pharmaceutical compositions of resveratrol
CN106581028A (en) * 2016-11-30 2017-04-26 南宁市浩特竹鼠养殖场 Western medicine for curing cold of bamboo rat and preparation method of western medicine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753359A (en) * 1993-06-11 1995-02-28 Kao Corp Lipoxygenase inhibitor
FR2778337B1 (en) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med ARYLHYDROCARBON RECEPTOR LIGAND ANTAGONISTS
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
ATE324105T1 (en) * 1998-09-08 2006-05-15 Cornell Res Foundation Inc USE OF CYCLOOXYGENASE-2 INHIBITORS TO TREAT INFLAMMATORY DISEASES OF THE HEAD AND NECK

Also Published As

Publication number Publication date
JP2003505500A (en) 2003-02-12
CN1377262A (en) 2002-10-30
WO2001008671A2 (en) 2001-02-08
CA2379703A1 (en) 2001-02-08
EP1221949A2 (en) 2002-07-17
CO5200850A1 (en) 2002-09-27
TR200200246T2 (en) 2002-09-23
WO2001008671A3 (en) 2002-05-02
AU6240200A (en) 2001-02-19
PE20010540A1 (en) 2001-05-15

Similar Documents

Publication Publication Date Title
HUP0204123A3 (en) Compositions for prevention and treatment of cold and influenza-like symptoms, their preparation and use
HUP0402075A3 (en) Compositions for treatment of common cold
HK1089364A1 (en) Topical compositions and methods for treating pain
AU2002352483A1 (en) Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
PL336326A1 (en) Method of and composition for treating sleep apnoea
HK1049104A1 (en) Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
PL331708A1 (en) Treatment of common cold and allergic rhinitis
IL139658A0 (en) Pharmaceutical compositions for treatment and prophylaxis and method for their preparation
ZA991053B (en) Method and composition for treatment of inflammatory conditions.
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
EP1581095A4 (en) Therapeutic methods for reducing fat deposition and treating associated conditions
TW489827U (en) Apparatus for high-temperature and high-pressure treatment of semiconductor substrates
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
IL154354A0 (en) Composition for prophylaxis and treatment of cancer
AU2466399A (en) Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections
AU2002348299A8 (en) Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
AU2420101A (en) Method and composition for the treatment of pain
AU2001274552A1 (en) Method of fundamentally treating common cold
EP1096927A4 (en) Composition for treatment of stress
EP1330271A4 (en) Use of transcription factors for treating inflammation and other diseases
EP1189584A4 (en) Alpha amino acid composition and method for the treatment of skin
AU2149600A (en) Methods and compositions for treating common cold symptoms
HUP0200005A3 (en) Composition for the treatment of psoriasis and process for its preparation
PL355850A1 (en) Method and composition for the treatment of pain